Heparin sodium is mucopolysaccharide sulfate anticoagulant. Usually 10mg can anticoagulate 100ml of blood. Recent studies have proved that heparin sodium can also reduce blood lipid.

　　Function and use: this product has rapid anticoagulant action in vivo or in vitro. This product mainly acts on the formation of fibrin, but also can reduce platelet aggregation. This product can be used for the prevention and treatment of thromboembolic diseases, such as myocardial infarction, pulmonary embolism, cerebrovascular embolism, peripheral venous thrombosis, etc., can prevent the formation and expansion of thrombosis. It can also be used in the early stage of DIC and other anticoagulation in vivo and in vitro.

　　Pharmacology and toxicology: due to the physical and chemical properties of this product with strong negative charge, it can interfere with many links of blood coagulation process, and has anticoagulation effect in vivo and in vitro. Its mechanism of action is complicated, mainly through binding with antithrombin ⅲ (AT- ⅲ), and enhancing the inhibition of antithrombin ⅲ on activated ⅱ, ⅸ, ⅹ, ⅺ and ⅻ coagulation factors. The consequences involve preventing platelet aggregation and destruction and preventing the formation of clot-activating enzymes; Prevent prothrombin from becoming thrombin; Inhibits thrombin and thus prevents fibrinogen from becoming fibrin.

　　Heparin sodium Is the Manufacturer of Heparin sodium.